ReviewPrenatal diagnosis2020
SARS-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care.
Review in Prenatal diagnosis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- SARS-CoV-2 in early pregnancy-does it affect the aneuploidy screening markers and cause pregnancy loss?Irish journal of medical science · 2024Article
- Increase in cesarean sections in Brazil - a call to reflection.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2023Article
- Specialty grand challenge editorial innovative approaches for pharmacoepidemiologic research in pregnancy: Shifting the paradigm of Thalidomide's impact on pregnant women.Frontiers in drug safety and regulation · 2023Article
- New Zealand maternity and midwifery services and the COVID-19 response: A systematic scoping review.Women and birth : journal of the Australian College of Midwives · 2022Article
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy. A Non-systematic Review of Clinical Presentation, Potential Effects of Physiological Adaptations in Pregnancy, and Placental Vascular Alterations.Frontiers in physiology · 2022Review
- [Impact of SARS-CoV-2/COVID-19 on the placenta].Der Pathologe · 2021Review
- Pharmacological Treatments against COVID-19 in Pregnant Women.Journal of clinical medicine · 2021Review
- Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19Turkish journal of obstetrics and gynecology · 2021Article
- Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in pregnancy - An overview.European journal of obstetrics, gynecology, and reproductive biology · 2021Review
- Management and Prevention of COVID-19 in Pregnancy and Pandemic Obstetric Care: A Review of Current Practices.Healthcare (Basel, Switzerland) · 2021Review
- Placental Pathology Findings during and after SARS-CoV-2 Infection: Features of Villitis and Malperfusion.Pathobiology : journal of immunopathology, molecular and cellular biology · 2021Article
- The Impact of the Coronavirus Disease 19 Pandemic on Early Pregnancy Outcomes Among Patients UndergoingWomen's health reports (New Rochelle, N.Y.) · 2021Article
- SARS-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care.Prenatal diagnosis · 2020Review
- Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s.Prenatal diagnosis · 2020Review
- COVID-19 in pregnancy: Placental and neonatal involvement.American journal of reproductive immunology (New York, N.Y. : 1989) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since December 2019, the novel SARS-CoV-2 outbreak has resulted in millions of cases and more than 200 000 deaths worldwide. The clinical course among nonpregnant women has been described, but data about potential risks for women and their fetus remain scarce. The SARS and MERS epidemics were responsible for miscarriages, adverse fetal and neonatal outcomes, and maternal deaths. For COVID-19 infection, only nine cases of maternal death have been reported as of 22 April 2020, and pregnant women seem to develop the same clinical presentation as the general population. However, severe maternal cases, as well as prematurity, fetal distress, and stillbirth among newborns have been reported. The SARS-CoV-2 pandemic greatly impacts prenatal management and surveillance and raise the need for clear unanimous guidelines. In this narrative review, we describe the current knowledge about coronaviruses (SARS, MERS, and SARS-CoV-2) risks and consequences on pregnancies, and we summarize available current candidate therapeutic options for pregnant women. Finally, we compare current guidance proposed by The Royal College of Obstetricians and Gynaecologists, The American College of Obstetricians and Gynecologists, and the World Health Organization to give an overview of prenatal management which should be utilized until future data appear.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.